CClinicalTrials.gg
RecruitingNCT06544876DPNUpdated Aug 9, 2024

Balance Control and Recovery in Diabetes Peripheral Neuropathy

An interventional study of sit-to-stand and stand to sit in Diabetic Peripheral Neuropathy, Diabetic Peripheral Neuropathy Type 2 and Diabetic Peripheral Neuropathy Type 2 - Uncontrolled, sponsored by Lisa Griffin. Recruiting at 1 site in United States. Open to participants aged 50 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-09.

Sponsored by Lisa Griffin · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Sep 2023, registered Jul 2024).
  • Started Sep 2023; still recruiting 3 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
50 Years to 99 Years
Sex
All
01

Study summary

In this study the effects of diabetic peripheral neuropathy will be assessed on balance control, balance recovery, and muscle electrical activity in adults over 50 years.

Aim 1: Determine muscle activity and balance control during a sit-to-stand in adults age above 50 with and without diabetic peripheral neuropathy.

Aim 2: Assess local balance recovery and latency responses to lateral surface perturbation during quiet standing.

Read the detailed description

Diabetic peripheral neuropathy (DPN) is a common condition affecting patients with diabetes. The prevalence of DPN increases with age and the duration of having diabetes. Approximately 30% of patients with diabetes have peripheral neuropathy globally, and 4.5 million Americans have DPN.

DPN typically affects more distal peripheral nerve branches, resulting in sensory loss. DPN causes axonal damage and leads to a loss of muscle strength. These degenerative effects significantly contribute to fall risks and feelings of instability.

Falls most commonly occur during transitional tasks such as the sit-to-stand (STS) and stand-to-sit (StandTS). The overall objective of this study to assess the effects of DPN on balance control and muscle activity during transitional tasks (STS and StandTS) and during lateral perturbation while standing.

Study procedures:

  1. Measures of body weight, height, and limb diameter and measuring including leg length, knee width, elbow width, wrist width, and hand thickness.
  2. Measures of sensation of the big toe and heel area for both legs.
  3. Surface sensors will be placed on the leg muscles using non-allergic double adhesive tape.
  4. Participants will sit down and stand up on a chair with adjustable height.
  5. Then, participants will be asked to stand on a treadmill holding a ruler. The treadmill will slightly move left and right, and the muscle activity and balance control will be evaluated.
  6. Finally, muscle strength of the legs' muscles will be collected.
02

Conditions studied

  • Diabetic Peripheral Neuropathy
  • Diabetic Peripheral Neuropathy Type 2
  • Diabetic Peripheral Neuropathy Type 2 - Uncontrolled
  • Healthy Aging

Keywords

  • diabetic peripheral neuropathy
  • balance
  • sensation
  • aging
  • older adult
  • foot
  • sit-to-stand
  • falls
  • falling
03

In context

Peripheral Nervous System Diseases

1,003 studies on the registry are indexed under Peripheral Nervous System Diseases; 177 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 768 interventional studies indexed under Peripheral Nervous System Diseases.

Browse Peripheral Nervous System Diseases studies →

Lead sponsor

This is the only study on the registry with Lisa Griffin as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Type II diabetes with peripheral neuropathy

Exclusion criteria

Exclusion Criteria:

  • Foot ulcer
  • Partial amputation
  • Have experience of Stroke
  • Painful neuropathy
  • Inability to stand or walk independently
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    healthy younger adult

    Behavioral: sit-to-stand · Behavioral: stand to sit · Behavioral: standing perturbation · Other: MRI of sciatic nerve

  • Active comparator
    Healthy older adult

    Behavioral: sit-to-stand · Behavioral: stand to sit · Behavioral: standing perturbation · Other: MRI of sciatic nerve

  • Experimental
    older adult with diabetic peripheral neuropathy

    Behavioral: sit-to-stand · Behavioral: stand to sit · Behavioral: standing perturbation · Other: MRI of sciatic nerve

Interventions

  • Behavioralsit-to-stand

    test for balance during movement from sitting to standing

  • Behavioralstand to sit

    test for balance during movement from standing to sitting

  • Behavioralstanding perturbation

    test for balance recovery following perturbation

  • OtherMRI of sciatic nerve

    measure of peripheral nerve diameter

06

What researchers measure

Primary outcomes

  1. Center of pressure using force plate

    Center-of-pressure sway will be assessed between groups. As participants sit down or stand up from a chair on the force plates, the ground reaction force will be collected. Then, using a mathematical approach, an ellipse will be fitted to the data to calculate the sway area. A higher sway area indicates an impairment during balance control.

    Time frame: First session (immediately after intervention)

  2. Center of mass using Vicon cameras.

    Center-of-mass sway volume will be assessed as the participant will walk in front of a high-speed camera, which will be recorded using the retroreflective markers. Then, a mathematical approach will be used to fit an ellipsoid to the data samples for each group. Higher sway volume means impairment in balance.

    Time frame: First session (immediately after intervention)

  3. Joint moment using Nexus software

    Joint moments will be assessed between groups using Vicon and force plates. This variable will be obtained using Nexus software, which combines both the inputs from Vicon and force plates.

    Time frame: First session (immediately after intervention)

  4. Local dynamic stability using Motek and Vicon system

    Local dynamic stability will be assessed using the Motek treadmill and Vicon cameras. The Motek treadmill will provide the left and right perturbation, and the Vicon system will collect the kinematic data. Then, the MATLAB code will calculate local dynamic stability to identify impairment in balance recovery.

    Time frame: First session (immediately after intervention)

Secondary outcomes

  1. Muscle amplitude using root mean square

    Muscle amplitude will be collected using Delsys Tringo wireless surface electromyography (EMG). The EMG electrodes will be attached with double adhesive tape. Then, EMG amplitudes will be assessed using the root mean square technique in MATLAB software. Higher amplitude represents higher muscle activity.

    Time frame: First session (immediately after intervention)

  2. Muscle onset time using electromyography

    The muscle onset time will be assessed using MATLAB code. An abrupt change in the EMG trace is defined as a muscle onset time. Any change in EMG onset time represents impairment in neuromuscular junctions or muscle and nerve electrical conduction.

    Time frame: First session (immediately after intervention)

  3. Muscle co-activation index using EMG

    The coactivation index will be assessed between two muscles in the same participant using MATLAB syntax. An increase in muscle coactivation represents an increase in active joint stiffness. This increase in active joint stiffness reduces the resultant joint moment, leading to impaired smoothness of movement and reducing the ability to perform daily activities.

    Time frame: First session (immediately after intervention)

  4. Muscle energy frequency using EMG data

    Wavelet transform can identify the contribution of different muscle fibers (large or small, fast or slow twitch fibers) in the same task. Assessment of this method indicates what fiber type is affected by DPN.

    Time frame: First session (immediately after intervention)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06544876
Lead sponsor
Lisa Griffin
Responsible party
Lisa Griffin (Associate Professor, University of Texas at Austin) — Sponsor-investigator
First posted
Aug 9, 2024
Start date
Sep 12, 2023
Primary completion
Aug 31, 2026 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
Aug 9, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion